These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm. Chang LB, Tsai CP, Liao KK, Kao KP, Yuan CL, Yen DJ, Lin KP. Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705 [Abstract] [Full Text] [Related]
4. [Hemifacial spasm]. Krystkowiak P. Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481 [Abstract] [Full Text] [Related]
12. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP, Lang AE. CMAJ; 1988 Nov 01; 139(9):837-44. PubMed ID: 3052771 [Abstract] [Full Text] [Related]
13. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore. Tan AK. Singapore Med J; 1998 Sep 01; 39(9):403-5. PubMed ID: 9885719 [Abstract] [Full Text] [Related]
18. [Applications of botulin]. Lindberg L, Kanerva M, Pitkäranta A, Ansaranta M, Ylitalo L, Aaltonen LM, Pakarinen M, Salmenkylä S. Duodecim; 2011 Apr 01; 127(22):2431-43. PubMed ID: 22238921 [Abstract] [Full Text] [Related]
19. Botulinum toxin type B in blepharospasm and hemifacial spasm. Colosimo C, Chianese M, Giovannelli M, Contarino MF, Bentivoglio AR. J Neurol Neurosurg Psychiatry; 2003 May 01; 74(5):687. PubMed ID: 12700325 [No Abstract] [Full Text] [Related]
20. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review]. Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP. Arq Bras Oftalmol; 2006 May 01; 69(1):23-6. PubMed ID: 16491229 [Abstract] [Full Text] [Related] Page: [Next] [New Search]